FedEx Faces Class Action Lawsuit Over Tariff Refunds After Supreme Court Ruling 
Blackstone Expands BCRED Investor Payouts Amid Rising Private Credit Market Concerns 
Japan Signals Possible Currency Intervention as Yen Slides to 157.3 Amid Middle East Tensions 
Wall Street Closes Mixed as Tech Stocks Rally Despite U.S.–Iran Escalation and Oil Price Surge 
Strait of Hormuz LNG Crisis Triggers Global Energy Market Shock 
Qantas Shares Plunge 10% as Iran Strikes Send Oil Prices Soaring and Disrupt Global Flights 
Bank of Japan Signals Further Interest Rate Hikes as Inflation Trends Toward 2% Target 
Netflix Stock Jumps 14% After Exiting Warner Bros Deal as Paramount Seals $110 Billion Acquisition 
Japan Manufacturing PMI Jumps to Four-Year High as Global Demand Strengthens 
Trump Warns Iran as Gulf Conflict Disrupts Oil Markets and Global Trade 
Gold Prices Surge Over 2% After U.S.-Israel Strikes on Iran Spark Safe-Haven Demand 
Australia Housing Market Hits Record High Despite RBA Rate Hike 
South Korea Manufacturing PMI Rises for Third Month on Strong Semiconductor Demand 
China’s New Home Prices Post Sharpest Drop Since 2022 Amid Ongoing Property Slump 
PBOC Scraps Forex Risk Reserve as Yuan Rally Pressures Chinese Exporters 
United Airlines Boeing 787-9 Makes Emergency Landing in Los Angeles After Possible Engine Fire 
AWS Data Center in UAE Hit by Fire After Objects Strike Facility Amid Regional Tensions 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
